Skip to main content
Fig. 4 | Journal of Translational Medicine

Fig. 4

From: Integrative analysis and experiments to explore angiogenesis regulators correlated with poor prognosis, immune infiltration and cancer progression in lung adenocarcinoma

Fig. 4

Evaluation of the response sensitivity of chemotherapeutic drugs and molecular targeted drugs in high- and low-risk patients. AD Therapeutic response to chemotherapy drugs between high- and low-risk patients. EL Therapeutic response of targeted gene drugs of patients with LUAD in high- and low-risk groups

Back to article page